Skip to main content
. 2016 Oct 11;12:2587–2594. doi: 10.2147/NDT.S116029

Table 2.

Device-associated TEAEs experienced by >1 patient

Parameter Cohort 1
f(n=37), n (%)
Cohort 2
(n=30), n (%)
Total
(N=67), n (%)
Patients with TEAEs 13 (35.1) 9 (30.0) 22 (32.8)
 Pruritus 5 (13.5) 4 (13.3) 9 (13.4)
 Erythema 2 (5.4) 2 (6.7) 4 (6.0)
 Rash 3 (8.1) 0 (0) 3 (4.5)
 Dermatitis contact 2 (5.4) 1 (3.3) 3 (4.5)
 Rash erythematous 2 (5.4) 0 (0) 2 (3.0)
Severe TEAEs (rash) 1 (2.7) 0 (0) 1 (1.5)

Abbreviation: TEAE, treatment-emergent adverse event.